Group den Boer

Medicijnen en Levenswetenschappen

1. Precursor Cell Lymphoblastic Leukemia-Lymphoma 100%
2. B-Lymphoid Precursor Cells 48%
3. Pediatrics 40%
4. Residual Neoplasm 26%
5. Inotuzumab Ozogamicin 24%
6. B-Lymphocytes 17%
7. Leukemia 12%
8. Protein-Tyrosine Kinases 12%
9. Child 11%
10. condensin complexes 10%
11. Polyploidy 10%
12. Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 10%
13. Aurora Kinase B 10%
14. PCI 32765 9%
15. Recurrence 9%
16. Cytogenetics 9%
17. B-Cell Leukemia 9%
18. Janus Kinase Inhibitors 9%
19. Cohort Studies 9%
20. Gene Fusion 7%
21. Gene Deletion 7%
22. Survival 7%
23. Down Syndrome 6%
24. Autophagy 6%
25. Therapeutics 6%
26. Confidence Intervals 6%
27. Drug Resistance 6%
28. Progression-Free Survival 5%
29. Stem Cells 5%
30. Pre-B Cell Receptors 5%
31. Asparaginase 5%
32. MicroRNAs 5%
33. Risk Assessment 5%